DelveInsight’s, “Sleep Apnea Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 14+ pipeline drugs in Sleep Apnea pipeline landscape. It covers the Sleep Apnea ...

Incannex Healthcare Inc. (NASDAQ:IXHL) saw its stock jump 10% on Friday after positive Phase 2 trial results for its ...

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

Incannex's IHL-42X showed significant efficacy in Phase 2 sleep apnea trial, with strong AHI reduction, improved sleep, and ...

Sleep apnea is a common sleep disorder that causes abnormal breathing patterns as you sleep, like pauses in your breath. These interruptions can lead to fragmented sleep, excessive daytime fatigue ...

Researchers assessed the risk of age-related macular degeneration development and progression in individuals diagnosed with obstructive sleep apnea.

Millions of Canadians have sleep apnea, but many don't know it, doctors say. The good news is the condition is treatable, but the cost and access to that treatment varies a lot across the country ...